ST. LOUIS, MO--(Marketwire - Mar 18, 2013) - Stifel Financial Corp. (
"Healthcare continues to be an area of strategic importance to our franchise. Marc's addition to the team further solidifies our commitment to this sector, adding to our deep Healthcare Investment Banking platform. With one of the strongest teams in the industry, we are well-positioned to capitalize on the opportunities present in today's environment," commented Brad Raymond, Co-Head of Investment Banking at Stifel.
"We are very pleased that Marc has joined Stifel's Healthcare practice," stated Declan Quirke, Head of Healthcare Investment Banking. "With 15 years of investment banking experience working with companies in the healthcare space, Marc brings strong client relationships in an area where we see significant opportunity for growth."
Most recently, Dr. Grasso was a Managing Director in UBS's Global Healthcare Group, responsible for coverage of biopharmaceutical companies. Before joining UBS in 2010, Dr. Grasso was a Managing Director with Leerink Swann, where he was instrumental in the west coast expansion of their franchise. Dr. Grasso earned a Doctorate in Medicine from Johns Hopkins School of Medicine and an undergraduate degree in Molecular Biology from Princeton University.
Stifel Company Information
Stifel Financial Corp. (
- Investment & Company Information
- Investment Banking